Skip to main content
CODX
NASDAQ Industrial Applications And Services

Co-Diagnostics Reports Staggering $46.9M Net Loss, Going Concern Warning, and Significant Dilution Amidst Nasdaq Compliance Challenges

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$1.775
Mkt Cap
$3.897M
52W Low
$1.66
52W High
$46.5
52W Position info
6.9% above low
Off High info
96% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

CODX is trading near its 52-week low of $1.66 (6.9% above the low) on light trading volume (0.2× avg).

Summary

Co-Diagnostics reported a $46.9 million net loss for 2025, an 84% revenue decline, and received a 'going concern' warning. The company undertook significant dilutive capital raises and a reverse stock split to maintain Nasdaq compliance, and announced a 26% workforce reduction.


Key Events · Financing and Capital Events · CODX

  • Staggering Net Loss and Revenue Decline

    The company reported a net loss of $46.9 million for the fiscal year ended December 31, 2025, a significant increase from $37.6 million in 2024. Total revenue for 2025 plummeted by 84% to $0.6 million from $3.9 million in 2024.

  • Going Concern Warning Issued

    Both the independent registered public accounting firm and management have expressed substantial doubt about the company's ability to continue as a going concern, citing recurring losses from operations and negative operating cash flows.

  • Massive Impairment Charge

    Co-Diagnostics recognized an $18.9 million impairment charge related to in-process research and development intangible assets, primarily due to a significant decline in stock price and market capitalization.

  • Significant Dilutive Capital Raises

    The company completed two registered direct offerings in Q4 2025, raising approximately $10.8 million in gross proceeds. Additionally, it sold 31,667 shares under a new $10.0 million at-the-market (ATM) program by year-end, with further sales of 1,507,434 shares for $4.3 million in net proceeds occurring after December 31, 2025.


Analysis · CODX · Industrial Applications And Services

Co-Diagnostics' annual report reveals a company in severe financial distress, marked by a substantial net loss and an explicit 'going concern' warning from both management and auditors. The company's revenue has plummeted, and it incurred a massive impairment charge, highlighting operational challenges. While recent dilutive capital raises and a reverse stock split have temporarily addressed liquidity and Nasdaq listing requirements, the underlying financial performance and the ongoing legal risks present a highly challenging outlook. The subsequent workforce reduction underscores the need for drastic cost-cutting measures.

How filings like this one have moved

In the 30 days to Nov 6, 2026, 51% of the 202 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.71%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CODX was trading at $1.77 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.9M. The 52-week trading range was $1.66 to $46.50. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CODX - Latest Insights

CODX
Nov 04, 2026, 4:45 PM EST
Filing Type: S-3
Importance Score:
8
Price at Filing: $0.3615
Real-time Price: $0.2744 info
Change: -$0.0871 (-24%) info
Market Cap: $2.357M info
CODX
Oct 26, 2026, 4:00 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $0.5459
Real-time Price: $0.2744 info
Change: -$0.2715 (-50%) info
Market Cap: $2.357M info
CODX
Oct 19, 2026, 12:28 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.6726
Real-time Price: $0.2744 info
Change: -$0.3982 (-59%) info
Market Cap: $2.357M info
CODX
Oct 15, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.7201
Real-time Price: $0.2744 info
Change: -$0.4457 (-62%) info
Market Cap: $2.357M info
CODX
Oct 13, 2026, 6:10 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.23
Real-time Price: $0.2744 info
Change: -$0.9556 (-78%) info
Market Cap: $2.357M info